B2.022 Intro to Neurodegenerative Neuropathology Flashcards
where is atrophy especially prominent in a brain with AD?
temporal pole, medial temporal lobe (amygdala and hippocampus), frontal lobes, parietal lobes
what happens to a cortex with AD?
reduced volume (thin)
what happens to the ventricles in AD?
enlargement of lateral and 3rd (due to atrophy of amygdala and hippocampus)
how does the brain weight change in AD?
reduced due to cerebral atrophy and loss of brain volume
which part of the brain remains unaffected in AD?
cerebellum
are B amyloid plaques intra or extracellular?
extracellular
outline the Thal stages of B amyloidosis
- cortex
- amygdala, hippocampus
- thalamus
- brain stem
- cerebellum
how are the Thal stages used?
used in evaluation of people who die from neurodegenerative disease
what is vascular B amyloid?
smooth muscle in blood vessels is replaced by B-amyloid
what are some effects of vascular B amyloid?
can break and bleed causing possible hemorrhages even without hypertension
what is the definition of amyloid?
pathologic proteinaceous substance, deposited between cells in various tissues and organs of the body in a wide variety of clinical settings
describe the physical nature of amyloid?
made up largely of nonbranching fibrils of indefinite length, characteristic cross B pleated sheet conformation,
what is the distinctive staining associated with B amyloid?
birefringence of Congo red stained amyloid, switch between yellow and salmon colors with different filters
how do tau positive tangles differ from B amyloid plaques?
intracellular, different order of progression
what are two other protein aggregates associated with AD?
alpha synuclein (also associated w Parkinsons) TDP-43
what makes tau proteins abnormal?
hyperphosphorylation
what are some sources of misfolded proteins?
stress, cellular aging, mutations
oxidative stress: post translational modifications
what are the cellular responses to misfolded proteins?
refolding, degrading, or sequestering the proteins
what are mediators of protein degradation?
chaperone proteins, lysosomal pathways, ubiquitin-proteasome pathways
what are major contributors to atrophy?
dendritic and neuronal losses
what type of dementia is marked by focal frontal/temporal lobar atrophy?
frontal temporal dementias
what is associated with vascular dementia?
signal changes in white matter
what is an FGD-PET?
fluorodeoxyglucose PET scan, indicator of brain metabolism, hypometabolic regions (parietal, lateral, temporal, posterior cingulate) typical of AD
discuss hypometabolism as a robust biomarker of neurodegeneration
hypometabolism can be observed to precede the appearance of cognitive symptoms and to predict the rate of progressive cognitive decline in individuals who are later found to have progressed to AD
what new compound is used in imaging brain amyloid?
pittsburg compound B, based on thioflavin T
can you have AB plaques and not show clinical signs of AD?
yes; plaque builds over a long period of time and often does not show clinical symptoms at the beginning